NASA: Notice of Intent To Grant an Exclusive, Co-Exclusive or Partially Exclusive Patent License: BSK Health Partners, LLC
[Federal Register Volume 86, Number 115 (Thursday, June 17, 2021)] [Notices] [Pages 32284-32285] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2021-12756]
NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
[Notice: (21-035)]
Notice of Intent To Grant an Exclusive, Co-Exclusive or Partially Exclusive Patent License
AGENCY: National Aeronautics and Space Administration.
ACTION: Notice of intent to grant exclusive, co-exclusive or partially exclusive patent license.
SUMMARY: NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.
DATES: The prospective exclusive, co-exclusive or partially exclusive license may be granted unless NASA receives written objections including evidence and argument, no later than July 2, 2021 that establish that the grant of the license would not be consistent with the requirements regarding the licensing of federally owned inventions as set forth in the Bayh-Dole Act and implementing regulations. Competing applications completed and received by NASA no later than July 2, 2021 will also be treated as objections to the grant of the contemplated exclusive, co-exclusive or partially exclusive license. Objections submitted in response to this notice will not be made available to the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act.
FOR FURTHER INFORMATION CONTACT: Written objections relating to the prospective license or requests for further information may be submitted to Agency Counsel for Intellectual Property, NASA Headquarters at Email: hq-patentoffice@mail.nasa.gov. Questions may be directed to Helen Galus at (202) 358-3437.
SUPPLEMENTARY INFORMATION: NASA intends to grant an exclusive, co- exclusive, or partially exclusive patent license in the United States to practice the inventions described and claimed in: US 8,735,116 B2, High-Density Spot Seeding for Tissue Model Formation and US 9,243,223 B2, High-Density Spot Seeding for Tissue Model Formation to BSK Health Partners, LLC. having its principal place of business in North Richland Hills, Texas. The fields of use may be limited. NASA has not yet made a final determination to grant the requested license and may deny the requested license even if no objections are submitted within the comment period.
This notice of intent to grant an exclusive, co-exclusive or partially exclusive patent license is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). The patent rights in these inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective license will comply with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.
Information about other NASA inventions available for licensing can be found online at http://technology.nasa.gov.
Helen M. Galus, Agency Counsel for Intellectual Property. [FR Doc. 2021-12756 Filed 6-16-21; 8:45 am] BILLING CODE 7510-13-P
